Searched for
ELI LILLY DONANEMAB
Alzheimer's a key part of Eli Lilly's India specialty medicine push, says company's country head Winselow TuckerEli Lilly has introduced Lormalzi in India, a pioneering treatment for Alzheimer's that specifically targets amyloid plaques, a significant...13 May, 2026, 03.00 PM IST- India is well positioned to attract future investments, says Eli Lilly's Patrik JonssonEli Lilly's Patrik Jonsson urges India to accelerate regulatory review pathways to boost competitiveness, emphasizing the need for data pro...22 Mar, 2026, 12.54 PM IST
- India is well positioned to attract future investments: Patrik Jonsson, President, Lilly InternationalEli Lilly's Patrik Jonsson urges India to accelerate regulatory review pathways to boost competitiveness, emphasizing the need for stronger...22 Mar, 2026, 08.53 AM IST
- Eli Lilly sticks to premium pricing for its innovator drug ahead of generics waveEli Lilly remains optimistic about strong demand for its weight-loss and anti-diabetes injectable, tirzepatide (sold as Mounjaro), despite ...02 Mar, 2026, 12.09 AM IST
- Mounjaro-maker Eli Lilly targets India as global export hub amid booming sales, executive saysEli Lilly aims to establish India as a key hub for its global supply chain. The company plans to export drugs manufactured locally in India...17 Feb, 2026, 03.21 PM IST
- Eli Lilly get nod from CDSCO for it Alzheimer’s drug DonanemabEli Lilly has secured marketing authorization from India's CDSCO for its Alzheimer's drug, donanemab. This new disease-modifying therapy ta...18 Nov, 2025, 02.43 PM IST
- Alzheimer disease symptoms treatment: Can Alzheimer's be prevented? Doctors, health experts say yes, prescribe ways to check dementiaWhat makes people more at risk of getting Alzheimer's disease and dementia more broadly? Nearly half of all cases are linked to factors suc...20 Sep, 2025, 08.15 AM IST
- Alzheimer's treatment? New drug found to slow down ‘clinical decline’ of disorder; Know about the medicine, its impact, how it works and moreThe new Alzheimer’s drug, Donanemab has demonstrated the ability to decelerate "clinical decline" by as much as 35%, enabling individuals w...17 Jul, 2023, 10.18 PM IST
- New cancer-like rating system introduced for Alzheimer's diagnosisExperts have developed a new seven-point rating scale for diagnosing Alzheimer's disease based on cognitive and biological changes in patie...17 Jul, 2023, 08.26 AM IST
- Roche's Alzheimer's drug fails to meet goal in long awaited trialRoche's Alzheimer's drug candidate could not be shown to markedly slow dementia progression in two drug trials, leaving rivals Biogen and E...14 Nov, 2022, 02.50 PM IST
Load More
